REGN
Regeneron Pharmaceuticals, Inc.
$945.53−12.23 (−1.28%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Apr 2, 1991 – Nov 18, 2026, Dividends reinvested
- Final balance
- $451,812
- CAGR
- +11.29%
- Max drawdown
- −91.81%
Trailing returns (%)
REGN's average annual return was 9.16% over the last 10 years and 20.31% over the last 20 years, through Nov 18, 2026. $10,000 in REGN on Nov 18, 2016 grew to $24,013 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +19.58%
- 3M
- +16.70%
- 6M
- +50.56%
- YTD
- +22.97%
- 1Y
- +31.03%
Per year
- 3Y
- +5.95%
- 5Y
- +8.04%
- 10Y
- +9.16%
- 15Y
- +21.76%
- 20Y
- +20.31%
- 25Y
- +15.58%
- 30Y
- +13.87%
- Since 1991
- +11.29%
Annual returns
1991 from Apr 2 · 2026 through Nov 18
REGN returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +22.97% |
| 2025 | +8.96% |
| 2024 | −18.90% |
| 2023 | +21.73% |
| 2022 | +14.25% |
| 2021 | +30.72% |
| 2020 | +28.66% |
| 2019 | +0.53% |
| 2018 | −0.65% |
| 2017 | +2.42% |
| 2016 | −32.38% |
| 2015 | +32.33% |
Metrics
Since 1991| Volatility | 62.70% |
|---|---|
| Sharpe ratio | 0.48 |
| Sortino ratio | 0.76 |
| Calmar ratio | 0.12 |
| Longest drawdown | 11.2 years |
Worst drawdowns
Since 1991| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −91.8% | Feb 2000 | Apr 2005 | Apr 2011 | 11.2 years |
| −86.7% | Feb 1992 | Dec 1994 | Oct 1996 | 4.7 years |
| −77.4% | Oct 1996 | Apr 1999 | Feb 2000 | 3.4 years |
| −59.7% | Aug 2024 | Jun 2025 | Not yet | 2.2 years so far |
| −53.8% | Aug 2015 | Sep 2019 | May 2020 | 4.8 years |